XKRX:000100 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
121,900
-5,800 (-4.54%)
Feb 28
Business Description
Yuhan Corp
SIC : 2833
ISIN : KR7000100008
Share Class Description:
XKRX:000100: Ordinary SharesCompare
Compare
Traded in other countries / regions
000100.Korea Index Membership
KOSPIiShares MSCI ACWI Ex US Index Fund IPO Date
1962-11-01Description
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplements, household and animal care, and contract manufacturing of active pharmaceutical ingredients. The company offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 1.08 | |||||
Interest Coverage | 5.17 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 9.35 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | -13.4 | |||||
3-Year EPS without NRI Growth Rate | 14.4 | |||||
3-Year FCF Growth Rate | -0.6 | |||||
3-Year Book Growth Rate | 4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 10.88 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.58 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.86 | |||||
9-Day RSI | 40.29 | |||||
14-Day RSI | 42.71 | |||||
3-1 Month Momentum % | 12.31 | |||||
6-1 Month Momentum % | -8.09 | |||||
12-1 Month Momentum % | 92.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.3 | |||||
Quick Ratio | 1.79 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 79.98 | |||||
Days Sales Outstanding | 106.75 | |||||
Days Payable | 51.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.41 | |||||
Dividend Payout Ratio | 0.2 | |||||
3-Year Dividend Growth Rate | 11 | |||||
Forward Dividend Yield % | 0.41 | |||||
5-Year Yield-on-Cost % | 0.57 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | -0.77 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.64 | |||||
Operating Margin % | 3.62 | |||||
Net Margin % | 8.35 | |||||
FCF Margin % | -4.66 | |||||
ROE % | 8.2 | |||||
ROA % | 5.95 | |||||
ROIC % | 3.08 | |||||
3-Year ROIIC % | -2.1 | |||||
ROC (Joel Greenblatt) % | 17.68 | |||||
ROCE % | 8.2 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 53.7 | |||||
Forward PE Ratio | 62.34 | |||||
PE Ratio without NRI | 52.91 | |||||
Price-to-Owner-Earnings | 399.98 | |||||
PEG Ratio | 2.92 | |||||
PS Ratio | 4.38 | |||||
PB Ratio | 4.32 | |||||
Price-to-Tangible-Book | 5.01 | |||||
Price-to-Operating-Cash-Flow | 130.04 | |||||
EV-to-EBIT | 49.37 | |||||
EV-to-Forward-EBIT | 45.4 | |||||
EV-to-EBITDA | 37.44 | |||||
EV-to-Forward-EBITDA | 29.89 | |||||
EV-to-Revenue | 4.51 | |||||
EV-to-Forward-Revenue | 2.15 | |||||
EV-to-FCF | -96.87 | |||||
Price-to-GF-Value | 1.68 | |||||
Price-to-Projected-FCF | 7.44 | |||||
Price-to-Median-PS-Value | 1.77 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.8 | |||||
Price-to-Graham-Number | 3.44 | |||||
Price-to-Net-Current-Asset-Value | 18.24 | |||||
Earnings Yield (Greenblatt) % | 2.03 | |||||
FCF Yield % | -1.04 | |||||
Forward Rate of Return (Yacktman) % | 18.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yuhan Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 2,008,840.735 | ||
EPS (TTM) (â‚©) | 2270.048 | ||
Beta | 0.7 | ||
3-Year Sharpe Ratio | 0.83 | ||
3-Year Sortino Ratio | 1.71 | ||
Volatility % | 59.24 | ||
14-Day RSI | 42.71 | ||
14-Day ATR (â‚©) | 4561.672869 | ||
20-Day SMA (â‚©) | 127170 | ||
12-1 Month Momentum % | 92.28 | ||
52-Week Range (â‚©) | 65300 - 166900 | ||
Shares Outstanding (Mil) | 74.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Yuhan Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Yuhan Corp Stock Events
Event | Date | Price (â‚©) | ||
---|---|---|---|---|
No Event Data |
Yuhan Corp Frequently Asked Questions
What is Yuhan Corp(XKRX:000100)'s stock price today?
The current price of XKRX:000100 is â‚©121900.00. The 52 week high of XKRX:000100 is â‚©166900.00 and 52 week low is â‚©65300.00.
When is next earnings date of Yuhan Corp(XKRX:000100)?
The next earnings date of Yuhan Corp(XKRX:000100) is .
Does Yuhan Corp(XKRX:000100) pay dividends? If so, how much?
The Dividend Yield %  of Yuhan Corp(XKRX:000100) is 0.41% (As of Today), Highest Dividend Payout Ratio of Yuhan Corp(XKRX:000100) was 2.97. The lowest was 0.08. And the median was 0.24. The  Forward Dividend Yield % of Yuhan Corp(XKRX:000100) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |